XENON PHARMACEUTICALS INC.

Company

Xenon Pharmaceuticals Inc.

Filed

July 3, 2018

Accession Number

0000902664-18-002713

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →